Editor’s Note: This roundup is meant to highlight some of the most notable funding rounds of the month and is not intended to be comprehensive.
Health tech companies made several major funding announcements in August. Here is a list of some of the biggest funding rounds.
Cityblock raises $116 million in Series E funding
New York City-based Cityblock offers clinical care, behavioral health care and social care in patients’ homes, virtually and in community-based clinics. It primarily serves Medicaid and dual-eligible populations. The company’s AI-powered operating system aggregates physical, behavioral and social health data to provide care teams with predictive insights into members.
The $116 million round supported Cityblock’s acquisition of Homeward Health, a rural healthcare provider. The funding will be used to invest in the combined platform, including optimizing operations, the care model, technology and data infrastructure.
Happy Health secures $75 million in funding
Happy Health offers an FDA-cleared smart ring for at-home diagnosis of obstructive sleep apnea. It also provides treatment management and daily sleep health measurements. Happy Health’s platform uses continuous health data and AI to create a personalized baseline for each patient, helping doctors identify meaningful changes in their health. Sleep is the company’s first focus area, but it plans to expand into other areas in the future.
The $75 million round was from ARCH Venture Partners and OpenLoop. The financing will help Happy Health accelerate the clinical validation of its tech, as well as build the infrastructure to expand beyond sleep.
Flagler Health raises $50 million in Series B funding
New York City-based Flagler Health is an AI-native operating system for musculoskeletal care. It helps MSK practices run more efficiently and better manage patients between visits. The company supports thousands of providers across 36 states.
The Series B round was led by Bessemer Venture Partners, with participation from SignalFire, Alumni Ventures, Streamlined, 186 Ventures, Proof VC, Tribeca Venture Partners and Offscript. In total, Flagler Health has raised $63 million. The financing will help Flagler scale across the country, according to the announcement.
Network Bio launches with $50 million in funding
Palo Alto, California-based Network Bio is a biotechnology company building disease-specific AI models based on human biological data. It collaborates with academic medical centers and leverages its technology to accelerate diagnostics, biomarker discovery and drug development.
The $50 million raise was from Section 32, Thiel Bio, Founders Fund, Breyer Capital, Blue Venture Fund and JSL Health Capital. The funding will be used to expand Network Bio’s life science platform, according to the announcement.
Photo: DBenitostock, Getty Images
